Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Cash from Operations (2016 - 2026)

Ovid Therapeutics filings provide 11 years of Cash from Operations readings, the most recent being 13899000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 35.2% to 13899000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 41919000.0 through Mar 2026, up 15.4% year-over-year, with the annual reading at 38300000.0 for FY2025, 31.55% up from the prior year.
  • Cash from Operations hit 13899000.0 in Q1 2026 for Ovid Therapeutics, down from 10374000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4774000.0 in Q2 2025 and bottomed at 20086419.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 12303713.35, with a median of 12112000.0 recorded in 2023.
  • The largest annual shift saw Cash from Operations plummeted 112.48% in 2022 before it skyrocketed 66.51% in 2025.
  • Ovid Therapeutics' Cash from Operations stood at 9175732.0 in 2022, then decreased by 29.81% to 11911000.0 in 2023, then increased by 15.98% to 10008000.0 in 2024, then decreased by 3.66% to 10374000.0 in 2025, then plummeted by 33.98% to 13899000.0 in 2026.
  • Per Business Quant, the three most recent readings for OVID's Cash from Operations are 13899000.0 (Q1 2026), 10374000.0 (Q4 2025), and 12872000.0 (Q3 2025).